10 Pulmonary Hypertension Clinical Trials in Austin, TX (2026)

Q: How do I join a clinical trial in Austin?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Austin research site will contact you.

Recruiting Pulmonary Hypertension Studies in Austin

NCT06970067Recruiting

Co-Creating Active Middle School Communities to Increase Student Physical Activity

The purpose of this study is to identify community-level barriers and facilitators for active transport and leisure physical activity and to co-create and test the effectiveness and longer-term sustai...

Austin, TX450 participantsDeanna Hoelscher

View Study Details

NCT07145918Recruiting

A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia

Schizophrenia is a common and severe psychiatric illness characterized by extreme disturbances of cognition and thought, affecting language, perception and sense of self. This study will assess advers...

Austin, TX268 participantsAbbVie

View Study Details

NCT06667687Recruiting

Study to Evaluate Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-291 Moves Through the Body in Adult Participants With Non-Hodgkin's Lymphoma

Non-Hodgkin's lymphoma (NHL) is a cancer that arises from the transformation of normal B and T lymphocytes (white blood cells). The purpose of this study is to assess the safety, tolerability, pharmac...

Austin, TX165 participantsAbbVie

View Study Details

NCT07488676Recruiting

A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

This study will help find the most suitable dose of ASP546C in people with gastric cancer, gastroesophageal junction (GEJ) cancer, pancreatic cancer, and other specific solid tumors. GEJ is where the ...

Austin, TX150 participantsAstellas Pharma Global Development, Inc.

View Study Details

NCT07061288Recruiting

A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT

A study to evaluate the safety, tolerability, and PK of an injectable form of KarXT in participants with schizophrenia...

Austin, TX116 participantsBristol-Myers Squibb

View Study Details

NCT05607420Recruiting

Study Evaluating UCART20x22 in B-Cell Non-Hodgkin Lymphoma

First-in-human, open-label, dose-finding and dose-expansion study of UCART20x22 administered intravenously in subjects with relapsed or refractory B-Cell Non-Hodgkin Lymphoma (B-NHL). The purpose of t...

Austin, TX80 participantsCellectis S.A.

View Study Details

NCT07260253Recruiting

Remotely-supervised Neuromodulation in PPA

The goal of this clinical trial is to learn whether home-based brain stimulation combined with virtual speech-language therapy can improve communication abilities in adults with logopenic variant prim...

Austin, TX80 participantsMaya Henry

View Study Details

NCT05798897Recruiting

Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma

This study is a Phase 1 multicenter study with a Dose Escalation and Dose Expansion evaluating safety and efficacy of MT-601 administration to patients with Relapsed or Refractory Lymphoma. The starti...

Austin, TX79 participantsMarker Therapeutics, Inc.

View Study Details

NCT07615426Recruiting

A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia

The purpose of this study is to see how feasible it is to enroll participants with schizophrenia and for them to complete the study/assessments. It will also assess how safe and tolerable aticaprant i...

Austin, TX64 participantsJanssen Research & Development, LLC

View Study Details

NCT04150497Recruiting

Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)

This is a first-in-human, open-label, dose escalation and expansion study of UCART22 administered intravenously to patients with relapsed or refractory B-cell acute Lymphoblastic Leukemia (B-ALL). The...

Austin, TX52 participantsCellectis S.A.

View Study Details

About Pulmonary Hypertension Clinical Trials in Austin

Pulmonary hypertension is a type of high blood pressure that affects the arteries in the lungs and the right side of the heart. It can lead to heart failure if untreated. Treatment includes vasodilators, endothelin receptor antagonists, and PDE-5 inhibitors.

There are currently 10 pulmonary hypertension clinical trials recruiting participants in Austin, TX. These studies are seeking a combined 1,504 participants. Research is being sponsored by Deanna Hoelscher, AbbVie, Astellas Pharma Global Development, Inc. and 5 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pulmonary Hypertension Clinical Trials in Austin — FAQ

Are there pulmonary hypertension clinical trials in Austin?

Yes, there are 10 pulmonary hypertension clinical trials currently recruiting in Austin, TX. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Austin?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Austin research site will contact you about next steps.

Are clinical trials in Austin free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Austin studies also compensate for your time and travel.

What pulmonary hypertension treatments are being tested?

The 10 active trials in Austin are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary hypertension.

Data updated July 13, 2026 from ClinicalTrials.gov